Senior Director, Controller

Key Responsibilities

• Serve as BigHat's in-house technical accounting authority; research and prepare position memos on complex transactions, new GAAP pronouncements, and company-specific accounting policy decisions, analyzing and communicating risks and benefits effectively.
• Executes general ledger operations, leading financial close process to ensure accurate and timely US GAAP financial statements.
• Drive R&D accounting across CRO and vendor accruals, prepaids, and program-level cost tracking, bringing structure and visibility to one of the company's largest spend categories.
• Build and deliver financial reporting packages and board-level management decks; translate financial results and key metrics into clear narratives for executive leadership and the Board.
• Design, implement, and maintain a SOX compliance  internal control framework scaled for a high-growth company, balancing rigor with operational practicality as the company grows.
• Lead audit readiness; drive clean, timely delivery of annual financial statement audits in accordance with GAAP.
• Manage federal, state, and local tax compliance in coordination with external advisors; lead R&D tax credit studies and other R&D-related tax matters.
• Evaluate and implement AI-enabled tools and finance technology, including procure-to-pay and close management tools, to reduce manual effort, improve auditability, and strengthen data integrity at scale.
• Own payroll administration and equity accounting and plan administration under ASC 718 (including stock-based compensation expense, 409A valuation support, cap table integrity, and related financial statement disclosures).
• Own NetSuite ERP implementation including processes and controls while maintaining segregation of duties.

Skills Knowledge and Expertise

• Bachelor's or Master's in Finance, Accounting or Business preferred. Active CPA license.
• 10+ years of professional experience in accounting, including 3+ years of experience in a public biotech company. 
• Prior Controller or Assistant Controller experience at a venture-backed biotech or life sciences company strongly preferred.
• Strong command of US GAAP and technical accounting standards.
• Big 4 audit experience.
• Hands-on public company reporting experience; have personally prepared or reviewed Forms 10-Q and 10-K at a public company.
• Experience with CRO/CDMO contract accounting and accrual estimation.
• Hands-on experience with NetSuite or a comparable ERP, including comfort operating through a system migration.
• Familiarity with SOX/ICFR build-out in a pre-IPO environment.
• A track record of embedding AI tools to accounting and finance workflows. 
• Experience managing and transitioning outsourced accounting or consultant relationships in-house.
• Demonstrated success in building and managing teams to achieve financial and business goals.
• Excellent communication skills, both written and verbal, with the ability to convey complex information to diverse audiences.
• Comfort with uncertainty and demonstrated ability to exercise sound judgment under tight timelines and independently determine appropriate action where precedent may not exist.
• Detail-oriented and results-driven with bias for action and sense of urgency.
• Ability to work in a fast-paced environment with high expectations and ability to effectively manage multiple competing priorities effectively.
• Strong project management skills and experience managing multiple vendors and external partners.
• Strong interpersonal and communication skills to influence, collaborate, resolve conflicts, and build consensus with diverse stakeholders.

Total Rewards

About
BigHat Biosciences designs safer, more effective biologic therapies for patients using machine learning and synthetic biology. BigHat integrates a wet lab for high-speed characterization with machine learning technologies to guide the search for better antibodies. We apply these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.BigHat is a Series B biotech outside San Francisco with a team-oriented, inclusive, and family-friendly culture. Our broad pipeline of wholly-owned and partnered therapeutic programs span many disparate indications with high unmet need, such as cancer, inflammation, and infectious disease. BigHat has raised >$100M from top investors, including Section 32, a16z, and 8VC.